127 related articles for article (PubMed ID: 26784984)
1. The transport mechanism of integrin αvβ3 receptor targeting nanoparticles in Caco-2 cells.
Xu Y; Xu J; Shan W; Liu M; Cui Y; Li L; Liu C; Huang Y
Int J Pharm; 2016 Mar; 500(1-2):42-53. PubMed ID: 26784984
[TBL] [Abstract][Full Text] [Related]
2. Mechanism study of cellular uptake and tight junction opening mediated by goblet cell-specific trimethyl chitosan nanoparticles.
Zhang J; Zhu X; Jin Y; Shan W; Huang Y
Mol Pharm; 2014 May; 11(5):1520-32. PubMed ID: 24673570
[TBL] [Abstract][Full Text] [Related]
3. A novel ligand conjugated nanoparticles for oral insulin delivery.
Liu C; Shan W; Liu M; Zhu X; Xu J; Xu Y; Huang Y
Drug Deliv; 2016 Jul; 23(6):2015-25. PubMed ID: 26203690
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of cellular uptake and transport mediated by integrin receptor targeting trimethyl chitosan nanoparticles].
Xu J; Liu C; Xu YN; Shan W; Liu M; Huang Y
Yao Xue Xue Bao; 2015 Jul; 50(7):893-8. PubMed ID: 26552153
[TBL] [Abstract][Full Text] [Related]
5. Receptor mediated transcytosis in biological barrier: The influence of receptor character and their ligand density on the transmembrane pathway of active-targeting nanocarriers.
Song X; Li R; Deng H; Li Y; Cui Y; Zhang H; Dai W; He B; Zheng Y; Wang X; Zhang Q
Biomaterials; 2018 Oct; 180():78-90. PubMed ID: 30025247
[TBL] [Abstract][Full Text] [Related]
6. The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells.
He B; Lin P; Jia Z; Du W; Qu W; Yuan L; Dai W; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2013 Aug; 34(25):6082-98. PubMed ID: 23694903
[TBL] [Abstract][Full Text] [Related]
7. Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers.
Guan M; Zhu QL; Liu Y; Bei YY; Gu ZL; Zhang XN; Zhang Q
Int J Nanomedicine; 2012; 7():1921-30. PubMed ID: 22605938
[TBL] [Abstract][Full Text] [Related]
8. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
Ke Z; Guo H; Zhu X; Jin Y; Huang Y
J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
[TBL] [Abstract][Full Text] [Related]
9. Transport Mechanisms of Butyrate Modified Nanoparticles: Insight into "Easy Entry, Hard Transcytosis" of Active Targeting System in Oral Administration.
Wu L; Bai Y; Liu M; Li L; Shan W; Zhang Z; Huang Y
Mol Pharm; 2018 Sep; 15(9):4273-4283. PubMed ID: 30102863
[TBL] [Abstract][Full Text] [Related]
10. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y
Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321
[TBL] [Abstract][Full Text] [Related]
11. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
12. Complying with the physiological functions of Golgi apparatus for secretory exocytosis facilitated oral absorption of protein drugs.
Xing L; Zheng Y; Yu Y; Wu R; Liu X; Zhou R; Huang Y
J Mater Chem B; 2021 Feb; 9(6):1707-1718. PubMed ID: 33496710
[TBL] [Abstract][Full Text] [Related]
13. Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and their Related Cytotoxicology.
Chai GH; Xu Y; Chen SQ; Cheng B; Hu FQ; You J; Du YZ; Yuan H
ACS Appl Mater Interfaces; 2016 Mar; 8(9):5929-40. PubMed ID: 26860241
[TBL] [Abstract][Full Text] [Related]
14. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X
Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297
[TBL] [Abstract][Full Text] [Related]
15. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
17. A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid.
Liang Y; Li S; Wang X; He B; He B; Dai W; Zhang H; Wang X; Wang Y; Zhou D; Zhang Q
Theranostics; 2017; 7(13):3306-3318. PubMed ID: 28900511
[TBL] [Abstract][Full Text] [Related]
18. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S
Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208
[TBL] [Abstract][Full Text] [Related]
19. The combination of endolysosomal escape and basolateral stimulation to overcome the difficulties of "easy uptake hard transcytosis" of ligand-modified nanoparticles in oral drug delivery.
Cui Y; Shan W; Zhou R; Liu M; Wu L; Guo Q; Zheng Y; Wu J; Huang Y
Nanoscale; 2018 Jan; 10(3):1494-1507. PubMed ID: 29303184
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional Nanoparticles Enable Efficient Oral Delivery of Biomacromolecules via Improving Payload Stability and Regulating the Transcytosis Pathway.
Zheng Y; Wu J; Shan W; Wu L; Zhou R; Liu M; Cui Y; Zhou M; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Oct; 10(40):34039-34049. PubMed ID: 30207680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
